title: Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis.
authors.forename: Ana
authors.initials: A
authors.lastname: Lucas
authors.forename: Isabel
authors.initials: I
authors.lastname: Belinchón
authors.forename: María
authors.initials: M
authors.lastname: Pérez-Crespo
authors.forename: Javier
authors.initials: J
authors.lastname: Mataix
authors.forename: Isabel
authors.initials: I
authors.lastname: Betlloch
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000532:radiotherapy*; D012720:Severity of Illness Index; D014467:Ultraviolet Therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab